VALPROATE-INDUCED HEPATIC-FAILURE IN A CASE OF CYTOCHROME-C-OXIDASE DEFICIENCY

被引:34
作者
CHABROL, B [1 ]
MANCINI, J [1 ]
CHRETIEN, D [1 ]
RUSTIN, P [1 ]
MUNNICH, A [1 ]
PINSARD, N [1 ]
机构
[1] HOP ENFANTS MALAD,INSERM,UNITE RECH HANDICAPS GENET,F-75743 PARIS 15,FRANCE
关键词
HEPATIC FAILURE; COX DEFECT; VALPROATE; CHILD;
D O I
10.1007/BF01959226
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We report a 3 year-old girl with a myoclonic epilepsy. A fatal hepatic failure occurred after 3 months of valproate (VPA) therapy. In this patient, a defect of cytochrome c oxidase (COX) was demonstrated in her circulating lymphocytes. The enzyme was also found to be deficient in post-mortem liver and in cultured skin fibroblasts. However, a fully functional respiratory chain was found in muscle. VPA administration apparently triggered the hepatic failure, given this patient's background of partial COX deficiency.
引用
收藏
页码:133 / 135
页数:3
相关论文
共 16 条
  • [1] MITOCHONDRIAL CYTOCHROME DEFICIENCY PRESENTING AS A MYOPATHY WITH HYPOTONIA, EXTERNAL OPHTHALMOPLEGIA, AND LACTIC-ACIDOSIS IN AN INFANT AND AS FATAL HEPATOPATHY IN A 2ND COUSIN
    BOUSTANY, RN
    APRILLE, JR
    HALPERIN, J
    LEVY, H
    DELONG, GR
    [J]. ANNALS OF NEUROLOGY, 1983, 14 (04) : 462 - 470
  • [2] BREMER HJ, 1981, DISTURBANCES AMINOAC
  • [3] VALPROATE TOXICITY
    BROWN, JK
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1988, 30 (01) : 121 - 125
  • [4] HEPATIC-FAILURE IN DISORDERS OF OXIDATIVE-PHOSPHORYLATION WITH NEONATAL ONSET
    CORMIER, V
    RUSTIN, P
    BONNEFONT, JP
    RAMBAUD, C
    VASSAULT, A
    RABIER, D
    PARVY, P
    COUDERC, S
    PARROTROULAUD, F
    CARRE, M
    RISSE, JC
    CAHUZAC, C
    SAUDUBRAY, JM
    ROTIG, A
    HUBERT, P
    MUNNICH, A
    [J]. JOURNAL OF PEDIATRICS, 1991, 119 (06) : 951 - 954
  • [5] CARNITINE, VALPROATE, AND TOXICITY
    COULTER, DL
    [J]. JOURNAL OF CHILD NEUROLOGY, 1991, 6 (01) : 7 - 14
  • [6] VALPROIC ACID HEPATIC FATALITIES .2. US EXPERIENCE SINCE 1984
    DREIFUSS, FE
    LANGER, DH
    MOLINE, KA
    MAXWELL, JE
    [J]. NEUROLOGY, 1989, 39 (02) : 201 - 207
  • [7] GOODMAN SI, 1981, LABORATORY RES METHO, V6
  • [8] ASSOCIATIONS BETWEEN RISK-FACTORS FOR VALPROATE HEPATOTOXICITY AND ALTERED VALPROATE METABOLISM
    KONDO, T
    KANEKO, S
    OTANI, K
    ISHIDA, M
    HIRANO, T
    FUKUSHIMA, Y
    MURANAKA, H
    KOIDE, N
    YOKOYAMA, M
    [J]. EPILEPSIA, 1992, 33 (01) : 172 - 177
  • [9] MERLE P, 1980, H-S Z PHYSIOL CHEM, V361, P1257
  • [10] CLINICAL ASPECTS OF MITOCHONDRIAL DISORDERS
    MUNNICH, A
    RUSTIN, P
    ROTIG, A
    CHRETIEN, D
    BONNEFONT, JP
    NUTTIN, C
    CORMIER, V
    VASSAULT, A
    PARVY, P
    BARDET, J
    CHARPENTIER, C
    RABIER, D
    SAUDUBRAY, JM
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (04) : 448 - 455